EIKN · Eikon Therapeutics, Inc. · Exempt Offerings
$5.90
+0.06 (+1.03%)
At close · Nov 6
Return incl. dividend (before tax)
Market Cap
$319.57M
Shares
54.17M
Volume · Nov 6
402.39K
Avg daily vol (3M)
576.61K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-02-28 | New | Biotechnology | $399,999,934 | $350,700,037 | 06b |
| 2023-06-01 | New | Biotechnology | $534,999,983 | $140,759,782 | 06b |
| 2022-01-06 | New | Biotechnology | $524,999,783 | $517,764,785 | 06b |
| 2021-05-13 | New | Biotechnology | $107,811,248 | $102,537,782 | 06b |
Showing 1–4 of 4 filings
Key facts
CIK
1861123
CUSIP
282564103
13F (30d)
28 filings
28 filers
Visit website
Investor relations